Skip to main content
OpenTrials

Clinical trial condition

Cytopenia

Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.

57 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Cytopenia trial results

Active, not recruiting

Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant

NCT03301168

Conditions
Acute Lymphoblastic Leukemia, Anemia, Anemia, Aplastic, +34 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Stanford University - Division of Pediatric Stem Cell Transplant & Regenerative Medicine Palo Alto, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
View Trial Details
Completed

The National Myelodysplastic Syndromes (MDS) Study

NCT02775383

Conditions
Bone Marrow Diseases, Cytopenia, Hematologic Diseases, +4 more
Locations
  • Kaiser Permanente-Anaheim Anaheim, California, United States
  • Kaiser Permanente-Baldwin Park Baldwin Park, California, United States
  • Kaiser Permanente-Bellflower Bellflower, California, United States
  • Kaiser Permanente-Fontana Fontana, California, United States
View all 281 locations
View Trial Details
Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

NCT01928537

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Stanford University Cancer Center Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Medicine Chicago, Illinois, United States
  • University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
View all 35 locations
View Trial Details
Completed

Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome.

NCT01868477

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +6 more
Locations
  • Novartis Investigative Site Oran, Algeria
  • Novartis Investigative Site Sidi Bel Abbes, Algeria
  • Novartis Investigative Site CABA, Buenos Aires, Argentina
  • Novartis Investigative Site La Plata, Buenos Aires, Argentina
View all 30 locations
View Trial Details

Related conditions